U0126 protects PC12 cells against H2O2-induced
cell death. (a) Chemical structures of U0126, its inactive analogue
U0124, and other MEK inhibitors used in the study: trametinib, CI-1040,
PD318088, and pimasertib. (b) Representative images of H2O2-induced dead cells stained by propidium iodide. These
are accompanied by bright field images that show all cells. Scale
bar = 100 μm. (c) U0126 treatment shows reduced cell death compared
with DMSO (p < 0.002) and significantly lower
death rate compared with other MEK inhibitors. U0124 shows similar,
albeit to a lesser extent, protective effect. Control anti-oxidants,
trolox and ascorbic acid, demonstrate significant protective effect
toward oxidative stress. For each condition, the cell death percentage
is computed from 75 individual images taken from 3 independent sets
of experiments and each image comprises 150–250 cells (∼100 000
total number of cells). SEM error bars are depicted in the graph.
(d) U0126 shows protective effect against oxidative stress induced
by 0.01 units of glucose oxidase in glucose-supplemented medium for
12 h, while MEK inhibitors demonstrate similar high cell death rates
as to the DMSO control. Trolox and ascorbic acid demonstrate significant
protective effect toward oxidative stress. (e) Western blot of ERK
phosphorylation demonstrates that the MEK inhibitors U0126, trametinib
and pimasertib are effective in blocking ERK phosphorylation under
complete media (left panel), while U0124 results in slight ERK inhibition
compared to DMSO control. Serum starvation results in lack of ERK
phosphorylation in all conditions. (f) The cell-protective effect
of U0126 is concentration dependent and shows an EC50 of
about 100 nM.